Amgen (AMGN) Share-based Compensation (2009 - 2026)
Amgen's quarterly Share-based Compensation came in at $75.0 million in Q1 2026, down 11.76% year-on-year from $85.0 million in Q1 2025, and down 40.0% quarter-over-quarter from $125.0 million in Q4 2025.
Amgen has reported Share-based Compensation for 14 years, with the latest figure at $75.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 11.76% year-over-year to $75.0 million; the trailing twelve-month figure through Mar 2026 stood at $484.0 million (down 5.47% YoY), and the FY2025 full-year result was $494.0 million, down 6.79% from the prior year.
- Share-based Compensation for Q1 2026 stood at $75.0 million, down from $125.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $161.0 million in Q4 2023, with the low at $47.0 million in Q1 2023.
- Average Share-based Compensation over 4 years is $117.7 million, with a median of $125.0 million recorded in 2025.
- Year-over-year, Share-based Compensation surged 119.15% in 2024 and dropped 17.48% in 2025.
- Tracing AMGN's Share-based Compensation over 4 years: stood at $161.0 million in 2023, then dropped by 16.77% to $134.0 million in 2024, then decreased by 6.72% to $125.0 million in 2025, then sank by 40.0% to $75.0 million in 2026.
- The last three Share-based Compensation figures came in at $75.0 million (Q1 2026), $125.0 million (Q4 2025), and $127.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 161.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 300.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 444.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 185.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 218.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 272.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 146.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 125.00 Mn |
| Dec 31, 2025 | 125.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 157.00 Mn |
| Jun 30, 2025 | 157.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Sep 30, 2024 | 136.00 Mn |
| Sep 30, 2024 | 136.00 Mn |
| Jun 30, 2024 | 157.00 Mn |
| Jun 30, 2024 | 157.00 Mn |
| Mar 31, 2024 | 103.00 Mn |
| Mar 31, 2024 | 103.00 Mn |
| Dec 31, 2023 | 161.00 Mn |
| Dec 31, 2023 | 161.00 Mn |
| Sep 30, 2023 | 104.00 Mn |
| Sep 30, 2023 | 104.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 47.00 Mn |
| Mar 31, 2023 | 47.00 Mn |
| Dec 31, 2018 | 87.00 Mn |
| Dec 31, 2018 | 87.00 Mn |
| Sep 30, 2018 | 77.00 Mn |
| Sep 30, 2018 | 77.00 Mn |
| Jun 30, 2018 | 93.00 Mn |
| Jun 30, 2018 | 93.00 Mn |
| Mar 31, 2018 | 54.00 Mn |
| Mar 31, 2018 | 54.00 Mn |
| Dec 31, 2017 | 85.00 Mn |
| Dec 31, 2017 | 85.00 Mn |
| Sep 30, 2017 | 88.00 Mn |
| Sep 30, 2017 | 88.00 Mn |
| Jun 30, 2017 | 96.00 Mn |
| Jun 30, 2017 | 96.00 Mn |
| Mar 31, 2017 | 60.00 Mn |
| Mar 31, 2017 | 60.00 Mn |
| Dec 31, 2016 | 89.00 Mn |
| Dec 31, 2016 | 89.00 Mn |
| Sep 30, 2016 | 83.00 Mn |
| Sep 30, 2016 | 83.00 Mn |
| Jun 30, 2016 | 87.00 Mn |
| Jun 30, 2016 | 87.00 Mn |
| Mar 31, 2016 | 52.00 Mn |
| Mar 31, 2016 | 52.00 Mn |
| Dec 31, 2015 | 80.00 Mn |
| Dec 31, 2015 | 80.00 Mn |
| Sep 30, 2015 | 82.00 Mn |
| Sep 30, 2015 | 82.00 Mn |
| Jun 30, 2015 | 90.00 Mn |
| Jun 30, 2015 | 90.00 Mn |
| Mar 31, 2015 | 70.00 Mn |
| Mar 31, 2015 | 70.00 Mn |
| Dec 31, 2014 | 106.00 Mn |
| Dec 31, 2014 | 106.00 Mn |
| Sep 30, 2014 | 103.00 Mn |
| Sep 30, 2014 | 103.00 Mn |
| Jun 30, 2014 | 112.00 Mn |
| Jun 30, 2014 | 112.00 Mn |
| Mar 31, 2014 | 87.00 Mn |
| Mar 31, 2014 | 87.00 Mn |
| Dec 31, 2013 | 99.00 Mn |
| Dec 31, 2013 | 99.00 Mn |
| Sep 30, 2013 | 100.00 Mn |
| Sep 30, 2013 | 100.00 Mn |
| Jun 30, 2013 | 112.00 Mn |
| Jun 30, 2013 | 112.00 Mn |
| Mar 31, 2013 | 92.00 Mn |
| Mar 31, 2013 | 92.00 Mn |
| Dec 31, 2012 | 91.00 Mn |
| Dec 31, 2012 | 91.00 Mn |
| Sep 30, 2012 | 91.00 Mn |
| Sep 30, 2012 | 91.00 Mn |
| Jun 30, 2012 | 105.00 Mn |
| Jun 30, 2012 | 105.00 Mn |
| Mar 31, 2012 | 75.00 Mn |
| Mar 31, 2012 | 75.00 Mn |
| Dec 31, 2011 | 96.00 Mn |
| Dec 31, 2011 | 96.00 Mn |
| Sep 30, 2011 | 71.00 Mn |
| Sep 30, 2011 | 71.00 Mn |
| Jun 30, 2011 | 97.00 Mn |
| Jun 30, 2011 | 97.00 Mn |
| Mar 31, 2011 | 77.00 Mn |
| Mar 31, 2011 | 77.00 Mn |
| Dec 31, 2010 | 105.00 Mn |
| Dec 31, 2010 | 105.00 Mn |
| Sep 30, 2010 | 82.00 Mn |
| Sep 30, 2010 | 82.00 Mn |
| Jun 30, 2010 | 98.00 Mn |
| Jun 30, 2010 | 98.00 Mn |
| Mar 31, 2010 | 68.00 Mn |
| Mar 31, 2010 | 68.00 Mn |
| Dec 31, 2009 | 75.00 Mn |
| Dec 31, 2009 | 75.00 Mn |
| Sep 30, 2009 | 86.00 Mn |
| Sep 30, 2009 | 86.00 Mn |
| Jun 30, 2009 | 64.00 Mn |
| Jun 30, 2009 | 64.00 Mn |
| Mar 31, 2009 | 59.00 Mn |
| Mar 31, 2009 | 59.00 Mn |